Decidual macrophages and their roles at the maternal-fetal interface

Yale Journal of Biology and Medicine

Volumn 85, Issue 1, 2012, Pages 105-118

  Houser, Brandy L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Antigen presenting cells; Lipids; Macrophages; NK cells; Pregnancy; Reproduction

Indexed keywords

CD1 ANTIGEN; CD14 ANTIGEN; GLYCOPROTEIN P 15095;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL HETEROGENEITY; CELL POPULATION; DECIDUA; DECIDUAL MACROPHAGE; EXTRACELLULAR MATRIX; FETOPLACENTAL UNIT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LIPID BLOOD LEVEL; LIPID METABOLISM; MACROPHAGE; MACROPHAGE FUNCTION; MATERNAL FETAL INTERFACE; MOLECULAR INTERACTION; NATURAL KILLER CELL; NEWBORN HEMOLYTIC DISEASE; NONHUMAN; PATHOGENESIS; PLACENTA DEVELOPMENT; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANCY COMPLICATION; REVIEW; SUPPRESSOR CELL; TISSUE GROWTH; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGEN-PRESENTING CELLS; DECIDUA; FEMALE; HUMANS; KILLER CELLS, NATURAL; MACROPHAGES; MATERNAL-FETAL EXCHANGE; PREGNANCY; REPRODUCTION;

EID: 84859363627     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Archibald JD. Fossil Evidence for a Late Cretaceous Origin of "Hoofed" Mammals. Science. 1996;272(5265):1150-3.
2. Cross JC. Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol. 2000;11(2):105-13.
3. Hunt JS. Stranger in a strange land. Immunol Rev. 2006;213:36-47.
4. Vogel P. The current molecular phylogeny of Eutherian mammals challenges previous interpretations of placental evolution. Placenta. 2005;26(8-9):591-6.
5. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6(8):584-94.
6. Wildman DE, Chen C, Erez O, Grossman LI, Goodman M, Romero R. Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc Natl Acad Sci USA. 2006;103(9):3203-8.
7. Tayade C, Black GP, Fang Y, Croy BA. Differential gene expression in endometrium, endometrial lymphocytes, and trophoblasts during successful and abortive embryo implantation. J Immunol. 2006;176(1):148-56.
8. von Rango U. Fetal tolerance in human pregnancy- a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett. 2008;115(1):21-32.
9. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med. 2003;198(8):1201-12.
10. Trundley A, Gardner L, Northfield J, Chang C, Moffett A. Methods for isolation of cells from the human fetal-maternal interface. Methods Mol Med. 2006;122:109-22.
11. Houser BL, Tilburgs T, Hill J, Nicotra ML, Strominger JL. Two unique human decidual macrophage populations. J Immunol. 2011;186(4):2633-42.
12. Sapin V, Blanchon L, Serre AF, Lemery D, Dastugue B, Ward SJ. Use of transgenic mice model for understanding the placentation: to- wards clinical applications in human obstetrical pathologies? Transgenic Res. 2001;10(5):377-98.
13. Arck PC, Rucke M, Rose M, Szekeres- Bartho J, Douglas AJ, Pritsch M, et al. Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online. 2008;17(1):101-13.
14. Gracia CR, Sammel MD, Chittams J, Hummel AC, Shaunik A, Barnhart KT. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies. Obstet Gynecol. 2005;106(5 Pt 1):993-9.
15. Heard DH, Hinde IT, Mynors LS. An experimental study of haemolytic disease of the newborn due to isoimmunization of pregnancy. J Hyg (Lond). 1949;47(2):119-31.
16. Landsteiner K, Wiener AS. Studies on an Agglutinogen (Rh) in Human Blood Reacting with Anti-Rhesus Sera and with Human Isoantibodies. J Exp Med. 1941;74(4):309-20.
17. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172(4379):603-6.
18. Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol. 2003;60(1):1-11.
19. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science. 2000;287(5452):498-501.
20. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203(9):2165-75.
21. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 2005;19(7):681-93.
22. Hjartardottir S, Leifsson BG, Geirsson RT, Steinthorsdottir V. Paternity change and the recurrence risk in familial hypertensive disorder in pregnancy. Hypertens Pregnancy. 2004;23(2):219-25.
23. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006;27(9-10):939-58.
24. Gleicher N. Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases. Clin Rev Allergy Immunol. 2010;39(3):194-206.
25. Moffett A, Hiby S. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum Reprod. 2009;24(8):2048-9.
26. Redman CW. Immunology of preeclampsia. Semin Perinatol. 1991;15(3):257-62.
27. Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology. 1996;7(3):240-4.
28. Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod. 1999;14(9):2268-73.
29. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol. 2002;187(5):1137-42.
30. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest. 2001;81(8):1143-52.
31. Pijnenborg R, Vercruysse L, Verbist L, Van Assche FA. Interaction of interstitial trophoblast with placental bed capillaries and venules of normotensive and pre-eclamptic pregnancies. Placenta. 1998;19(8):569-75.
32. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327(5966):656-61.
33. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958-69.
34. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177(10):7303-11.
35. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451-83.
36. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992;176(1):287-92.
37. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35.
38. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677-86.
39. Ghassabeh GH, De Baetselier P, Brys L, Noel W, Van Ginderachter JA, Meerschaut S, et al. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood. 2006;108(2):575-83.
40. Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE. The phenotype of murine wound macrophages. J Leukoc Biol. 2010; 87(1):59-67.
41. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7.
42. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539-45.
43. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002;161(3):947-56.
44. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162-74.
45. Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev. 2008;222:155-61.
46. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005;5(8):641-54.
47. Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res. 1990;50(15):4771-5.
48. Mantovani A. Cancer: an infernal triangle. Nature. 2007;448(7153):547-8.
49. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121-4.
50. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol. 2006;6(4):318-28.
51. Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol. 1999;162(6):3639-46.
52. Miller L, Hunt JS. Sex steroid hormones and macrophage function. Life Sci. 1996;59(1):1-14.
53. Jones LA, Anthony JP, Henriquez FL, Lyons RE, Nickdel MB, Carter KC, et al. Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology. 2008;125(1):59-69.
54. Abrahams VM, Kim YM, Straszewski SL, Romero R, Mor G. Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol. 2004;51(4):275-82.
55. Gardner L, Moffett A. Dendritic cells in the human decidua. Biol Reprod. 2003;69(4):1438-46.
56. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science. 2002;296(5566):298-300.
57. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 2005;307(5715):1630-4.
58. Steinman RM, Swanson J. The endocytic activity of dendritic cells. J Exp Med. 1995;182(2):283-8.
59. Lennon-Dumenil AM, Bakker AH, Maehr R, Fiebiger E, Overkleeft HS, Rosemblatt M, et al. Analysis of protease activity in live antigen- presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med. 2002;196(4):529-40.
60. Yates RM, Hermetter A, Taylor GA, Russell DG. Macrophage activation downregulates the degradative capacity of the phagosome. Traffic. 2007;8(3):241-50.
61. Pearson H. Reproductive immunology: Immunity's pregnant pause. Nature. 2002;420(6913):265-6.
62. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5(3):266-71.
63. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science. 1995;270(5236):630-3.
64. Collins MK, Tay CS, Erlebacher A. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest. 2009;119(7):2062-73.
65. Red-Horse K, Rivera J, Schanz A, Zhou Y, Winn V, Kapidzic M, et al. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest. 2006;116(10):2643-52.
66. Bradford BM, Sester DP, Hume DA, Mabbott NA. Defining the anatomical localisation of subsets of the murine mononuclear phagocyte system using integrin alpha X (Itgax, CD11c) and colony stimulating factor 1 receptor (Csf1r, CD115) expression fails to discriminate dendritic cells from macrophages. Immunobiology. 2011;216(11):1228-37.
67. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010;59(7):1648-56.
68. Tagliani E, Shi C, Nancy P, Tay CS, Pamer EG, Erlebacher A. Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1. J Exp Med. 2011;208(9):1901-16.
69. Miyazaki S, Tsuda H, Sakai M, Hori S, Sasaki Y, Futatani T, et al. Predominance of Th2-promoting dendritic cells in early human pregnancy decidua. J Leukoc Biol. 2003;74(4):514-22.
70. Brizzi P, Tonolo G, Esposito F, Puddu L, Dessole S, Maioli M, et al. Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol. 1999;181(2):430-4.
71. Jeon H, Blacklow SC. Structure and physiologic function of the low-density lipoprotein receptor. Annu Rev Biochem. 2005;74:535-62.
72. Barral DC, Brenner MB. CD1 antigen presentation: how it works. Nat Rev Immunol. 2007;7(12):929-41.
73. Dascher CC, Brenner MB. Evolutionary constraints on CD1 structure: insights from com- parative genomic analysis. Trends Immunol. 2003;24(8):412-8.
74. Martin LH, Calabi F, Lefebvre FA, Bilsland CA, Milstein C. Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. Proc Natl Acad Sci USA. 1987;84(24):9189-93.
75. Longley J, Kraus J, Alonso M, Edelson R. Molecular cloning of CD1a (T6), a human epidermal dendritic cell marker related to class I MHC molecules. J Invest Dermatol. 1989;92(4):628-31.
76. Martin LH, Calabi F, Milstein C. Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc Natl Acad Sci USA. 1986;83(23):9154-8.
77. Grant EP, Degano M, Rosat JP, Stenger S, Modlin RL, Wilson IA, et al. Molecular recognition of lipid antigens by T cell receptors. J Exp Med. 1999;189(1):195-205.
78. Pena-Cruz V, Ito S, Dascher CC, Brenner MB, Sugita M. Epidermal Langerhans cells efficiently mediate CD1a-dependent presentation of microbial lipid antigens to T cells. J Invest Dermatol. 2003;121(3):517-21.
79. Grassi F, Dezutter-Dambuyant C, McIlroy D, Jacquet C, Yoneda K, Imamura S, et al. Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol. 1998;64(4):484-93.
80. Caux C, Vanbervliet B, Massacrier C, Dezutter- Dambuyant C, de Saint-Vis B, Jacquet C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med. 1996;184(2):695-706.
81. Smith ME, Thomas JA, Bodmer WF. CD1c antigens are present in normal and neoplastic B-cells. J Pathol. 1988;156(2):169-77.
82. Small TN, Knowles RW, Keever C, Kernan NA, Collins N, O'Reilly RJ, et al. M241 (CD1) expression on B lymphocytes. J Immunol. 1987;138(9):2864-8.
83. Plebani A, Proserpio AR, Guarneri D, Buscaglia M, Cattoretti G. B and T lymphocyte subsets in fetal and cord blood: age-related modulation of CD1c expression. Biol Neonate. 1993;63(1):1-7.
84. Porcelli SA. The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol. 1995;59:1-98.
85. Moody DB, Zajonc DM, Wilson IA. Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol. 2005;5(5):387-99.
86. Briken V, Moody DB, Porcelli SA. Diversification of CD1 proteins: sampling the lipid content of different cellular compartments. Semin Immunol. 2000;12(6):517-25.
87. Smed-Sorensen A, Moll M, Cheng TY, Lore K, Norlin AC, Perbeck L, et al. IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa. Blood. 2008;111(10):5037-46.
88. Leslie DS, Dascher CC, Cembrola K, Townes MA, Hava DL, Hugendubler LC, et al. Serum lipids regulate dendritic cell CD1 expression and function. Immunology. 2008;125(3):289-301.
89. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44-9.
90. Moretta A, Marcenaro E, Sivori S, Della Chiesa M, Vitale M, Moretta L. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol. 2005;26(12):668-75.
91. Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science. 2004;306(5701):1517-9.
92. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5(3):201-14.
93. Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol. 2009;9(8):568-80.
94. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986;319(6055):675-8.
95. Eissmann P, Davis DM. Inhibitory and regulatory immune synapses. Curr Top Microbiol Immunol. 2010;340:63-79.
96. King A, Wooding P, Gardner L, Loke YW. Expression of perforin, granzyme A and TIA-1 by human uterine CD56+ NK cells implies they are activated and capable of effector functions. Hum Reprod. 1993;8(12):2061-7.
97. Long EO. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev. 2008;224:70-84.
98. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B, et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA. 2005;102(43):15563-8.
99. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065-74.
100. Dietl J, Honig A, Kammerer U, Rieger L. Natural killer cells and dendritic cells at the human feto-maternal interface: an effective cooperation? Placenta. 2006;27(4-5):341-7.
101. Fernandez NC, Lozier A, Flament C, Ricciardi- Castagnoli P, Bellet D, Suter M, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999;5(4):405-11.
102. Chijioke O, Munz C. Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo. J Biomed Biotechnol. Epub 2011 Mar 31.
103. Carbone E, Terrazzano G, Melian A, Zanzi D, Moretta L, Porcelli S, et al. Inhibition of human NK cell-mediated killing by CD1 molecules. J Immunol. 2000;164(12):6130-7.
104. Campos-Martin Y, Gomez del Moral M, Gozalbo-Lopez B, Suela J, Martinez-Naves E. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis. J Immunol. 2004;172(12):7297-305.